Kodi chiyembekezo cha kansa ya m'matumbo chachikulu n'chiyani?
Chiyembekezo cha khansa ya m'matumbo chimadalira pa zinthu zingapo, kuphatikizapo mlingo wa khansa, msinkhu wa wodwalayo ndi thanzi lake lonse, ndi mphamvu ya mankhwala.
Kaŵirikaŵiri, khansara ikapezeka ndi kuchiritsidwa msanga, chiyembekezo chimakhala chabwino.
Malinga ndi American Cancer Society, chiŵerengero cha moyo wa zaka zisanu cha khansa ya m'matumbo aakulu chili pafupifupi 65% kaamba ka masitepe onse ophatikizidwa.
Komabe, kwa khansa ya m'matumbo (gawo 1), mlingo wa moyo wa zaka zisanu ndi pafupifupi 90%, pamene kwa khansa ya m'matumbo yakutali (gawo 4), mlingo wa moyo wa zaka zisanu ndi pafupifupi 111%. Ndikofunika kuzindikira kuti izi ndi ziwerengero zokha ndipo zotsatira za munthu aliyense zingasiyane.
Li YD, Lv Z, Xie HY, Zheng SS: Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients. Hepatobiliary Pancreat Dis Int. 2019, 18 (5): 446-451.
Di W, Li X, Yang Q: Polysaccharide of Lactobacillus casei SB27 reduced colon cancer cell prognosis through mitochondrial damage by upregulation of HINT2. Asia Pac J Clin Oncol. 2022, (): .
Kong D, Li G, Yang Z, Cheng S, Zhang W, Feng L, Zhang K: Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes. BMC Cancer. 2022, 22 (1): 84.
Zeng C, Huang L, Zheng Y, Huang H, Chen L, Chi L: [Expression of transcriptional coactivator with PDZ-binding motif (TAZ) in colon cancer tissues and its clinical significance]. Zhonghua Wei Chang Wai Ke Za Zhi. 2015, 18 (11): 1154-7.
Tang S, Yuan X, Song J, Chen Y, Tan X, Li Q: Association analyses of the JAK/STAT signaling pathway with the progression and prognosis of colon cancer. Oncol Lett. 2019, 17 (1): 159-164.
Wang GQ, Lu ZH, Fang YJ, Chen G, Zhou ZW, Pan ZZ, Wan DS: [Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer]. Ai Zheng. 2009, 28 (9): 945-9.
Chodzikanira: zachipatala
Webusaitiyi imaperekedwa kaamba ka zolinga za maphunziro ndi chidziŵitso zokha ndipo si kupereka uphungu wa zachipatala kapena mautumiki a akatswiri.
Chonde dziŵani kuti ma neural net amene amapanga mayankho a mafunso, ndi osayenerera makamaka pankhani ya manambala. Mwachitsanzo, chiŵerengero cha anthu odwala matenda enaake.
Nthawi zonse funsani upangiri wa dokotala wanu kapena wothandizira wina waluso pankhani ya matenda. Musanyalanyaze upangiri wa zamankhwala kapena kuchedwetsa kufunafuna chifukwa cha china chake chomwe mwawerenga patsamba lino. Ngati mukuganiza kuti mungakhale ndi vuto ladzidzidzi, itanani 911 kapena pitani ku chipinda chadzidzidzi chapafupi nthawi yomweyo. Palibe ubale wa dokotala ndi wodwala womwe umapangidwa ndi tsamba ili kapena kugwiritsa ntchito kwake. Neither BioMedLib kapena antchito ake, kapena aliyense wothandizira patsamba lino, amapanga ziwonetsero zilizonse, zowonetsera kapena zomveka, zokhudzana ndi chidziwitso choperekedwa pano kapena kugwiritsa ntchito kwake.
Chodzikanira: ufulu wolemba
Lamulo la Digital Millennium Copyright Act la 1998, 17 U.S.C. § 512 (the DMCA) limapereka njira yothandizira eni ake omwe amakhulupirira kuti zinthu zomwe zikuwonekera pa intaneti zimaphwanya ufulu wawo pansi pa lamulo la copyright la US.
Zidziwitso ziyenera kutumizidwa polemba kudzera pa imelo (onani gawo la "Contact" pa adilesi ya imelo).
DMCA imafuna kuti chidziwitso chanu cha kuphwanya ufulu waumwini chiphatikizepo chidziwitso chotsatirachi: (1) kufotokoza kwa ntchito yotetezedwa ndi ufulu waumwini yomwe ndi nkhani ya kuphwanya ufulu waumwini; (2) kufotokoza kwa zomwe zikunenedwa kuti zikuphwanya ufulu waumwini ndi chidziwitso chokwanira kutilola kupeza zomwe zili; (3) zidziwitso zolumikizirana nanu, kuphatikiza adilesi yanu, nambala yafoni ndi adilesi ya imelo; (4) mawu anu oti muli ndi chikhulupiriro chabwino kuti zomwe zili m'njira yomwe akudandaula sizinaloledwe ndi mwiniwake wa ufulu waumwini, kapena wothandizila wake, kapena chifukwa cha lamulo lililonse;
(5) chikalata chanu, chosainidwa pansi pa chilango cha umboni wabodza, chakuti chidziŵitso chimene chili m'chidziŵitsocho n'cholondola ndipo kuti muli ndi ulamuliro wokakamiza kukhazikitsa ufulu waumwini umene akunena kuti waphwanyidwa;
ndi (6) siginecha yakuthupi kapena yamagetsi ya mwiniwake wa ufulu waumwini kapena munthu wololedwa kuchitapo kanthu m'dzina la mwiniwake wa ufulu waumwini.
Chonde titumizireni imelo ndi funso / lingaliro lililonse.
What is prognosis of colon cancer?
The prognosis of colon cancer depends on several factors, including the stage of the cancer, the patient's age and overall health, and the effectiveness of treatment.
In general, the earlier the cancer is detected and treated, the better the prognosis.
According to the American Cancer Society, the 5-year relative survival rate for colon cancer is about 65% for all stages combined.
However, for localized colon cancer (stage 1), the 5-year relative survival rate is about 90%, while for distant (stage 4) colon cancer, the 5-year relative survival rate is about 111%. It is important to note that these are only estimates and that individual outcomes may vary.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Pafupifupi
BioMedLib imagwiritsa ntchito makompyuta othandizira (ma algorithms ophunzirira makina) kuti apange mafunso ndi mayankho awiri.
Timayamba ndi zofalitsa za mankhwala a zamoyo zokwana 35 miliyoni za PubMed/Medline. Komanso, masamba a webusaiti ya RefinedWeb.
